Parametric Portfolio Associates’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-12,324
| Closed | -$737K | – | 4078 |
|
|
2019
Q4 | $737K | Buy |
12,324
+3,772
| +44% | +$142K | ﹤0.01% | 3213 |
|
|
2019
Q3 | $240K | Buy |
8,552
+616
| +8% | +$21K | ﹤0.01% | 3636 |
|
|
2019
Q2 | $300K | Buy |
7,936
+2,040
| +35% | +$78.4K | ﹤0.01% | 3585 |
|
|
2019
Q1 | $230K | Buy |
+5,896
| New | +$169K | ﹤0.01% | 3666 |
|
|
2018
Q4 | – | Sell |
-15,191
| Closed | -$601K | – | 4010 |
|
|
2018
Q3 | $601K | Sell |
15,191
-1,242
| -8% | -$46.3K | ﹤0.01% | 3346 |
|
|
2018
Q2 | $628K | Sell |
16,433
-6,123
| -27% | -$227K | ﹤0.01% | 3257 |
|
|
2018
Q1 | $678K | Buy |
22,556
+385
| +2% | +$13K | ﹤0.01% | 3200 |
|
|
2017
Q4 | $693K | Buy |
22,171
+919
| +4% | +$25.2K | ﹤0.01% | 3180 |
|
|
2017
Q3 | $595K | Sell |
21,252
-15,082
| -42% | -$328K | ﹤0.01% | 3320 |
|
|
2017
Q2 | $695K | Buy |
36,334
+19,274
| +113% | +$308K | ﹤0.01% | 3187 |
|
|
2017
Q1 | $291K | Sell |
17,060
-390
| -2% | -$6.31K | ﹤0.01% | 3442 |
|
|
2016
Q4 | $319K | Sell |
17,450
-40,966
| -70% | -$708K | ﹤0.01% | 3391 |
|
|
2016
Q3 | $1.04M | Buy |
+58,416
| New | +$887K | ﹤0.01% | 2781 |
|
Parametric Portfolio Associates's BOLD Position: Q1 2020 in Review
Parametric Portfolio Associates sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 12,324 shares — an estimated $737K sold.
Parametric Portfolio Associates first reported a position in BOLD in Q3 2016 and held it in 13 quarters. The position peaked at $1.04M in Q3 2016. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.
- Parametric Portfolio Associates reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
- Parametric Portfolio Associates sold 12,324 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $737K.
- Parametric Portfolio Associates first reported a position in Audentes Therapeutics, Inc in Q3 2016 and held it in 13 quarters.
- Parametric Portfolio Associates's Audentes Therapeutics, Inc position peaked at $1.04M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.
Based on Parametric Portfolio Associates's 13F filing for Q1 2020, filed 13 May 2020.